Search Results - Michael Recht
- Showing 1 - 10 results of 10
-
1
Transcutaneous auricular neurostimulation to reduce heavy menstrual bleeding in women with and without von Willebrand disease by Christopher J. Czura, Angela C. Weyand, Maureen K. Baldwin, Michael Recht, Michael Recht, Melanie A. McWade, Alejandro Covalin, Navid Khodaparast
Published in Frontiers in Medicine (2025-10-01)Get full text
Article -
2
Resource utilization and treatment costs of patients with severe hemophilia A: Real‐world data from the ATHNdataset by Michael Recht, Chunla He, Er. Chen, Dunlei Cheng, Paul Solari, David Hinds
Published in eJHaem (2022-05-01)Get full text
Article -
3
-
4
Incorporating the patient voice and patient engagement in GOAL‐Hēm: Advancing patient‐centric hemophilia care by Jonathan C. Roberts, Michael Recht, Sarah E. Gonzales, Justin Stanley, Michael Denne, Jorge Caicedo, Kenneth Rockwood
Published in Research and Practice in Thrombosis and Haemostasis (2022-01-01)Get full text
Article -
5
The Bleeding Disorders Research Collaborative by Leonard A. Valentino, Maria E. Santaella, Michelle L. Witkop, Raymond W. Stanhope, Sammie Valadez, Samantha A. Carlson, Halli Benasutti, Donna DiMichele, Michael Recht
Published in Blood Vessels, Thrombosis & Hemostasis (2025-11-01)Get full text
Article -
6
Etranacogene dezaparvovec (AMT-061 phase 2b): normal/near normal FIX activity and bleed cessation in hemophilia B by Annette Von Drygalski, Adam Giermasz, Giancarlo Castaman, Nigel S. Key, Susan Lattimore, Frank W.G. Leebeek, Wolfgang Miesbach, Michael Recht, Alison Long, Robert Gut, Eileen K. Sawyer, Steven W. Pipe
Published in Blood Advances (2019-11-01)Get full text
Article -
7
Natural history of preexisting AAV5 antibodies in adults with hemophilia B during the lead-in of the etranacogene dezaparvovec phase 3 study by Robert Klamroth, Michael Recht, Nigel S. Key, Wolfgang Miesbach, Steven W. Pipe, Radoslaw Kaczmarek, Douglass Drelich, Blanca Salazar, Sandra Le Quellec, Paul E. Monahan, Nicholas Galante, Paul van der Valk, Jacqueline Tarrant
Published in Molecular Therapy: Methods & Clinical Development (2025-09-01)Get full text
Article -
8
Completion of phase 2b trial of etranacogene dezaparvovec gene therapy in patients with hemophilia B over 5 years by Annette von Drygalski, Esteban Gomez, Adam Giermasz, Giancarlo Castaman, Nigel S. Key, Susan U. Lattimore, Frank W. G. Leebeek, Wolfgang A. Miesbach, Michael Recht, Paul E. Monahan, Sandra Le Quellec, Steven W. Pipe
Published in Blood Advances (2025-07-01)Get full text
Article -
9
A novel transcutaneous auricular neurostimulation electrode configuration for treatment of heavy menstrual bleeding: an open-label trial by Christopher J. Czura, Angela C. Weyand, Maureen K. Baldwin, Michael Recht, Caroline G. Benner, Kimiko Harada, Brooke L. Wade, Meghan Luellen, Michael J. Darrow, Melanie A. McWade, Alejandro Covalin, Navid Khodaparast
Published in Bioelectronic Medicine (2026-04-01)Get full text
Article -
10
Inhibitor development and clinical characteristics in children with severe hemophilia A in the ATHN 8 US cohort study by Courtney D. Thornburg, H. Marijke van den Berg, Martin Chandler, Lynn Malec, Matthew Manuel, Carrie O’Neill, Michael Recht, Elizabeth Taggart, Shannon L. Carpenter, Christine Knoll, Lynn Malec, Michael Wang, Michael Guerrera, Cristina Tarango, Robert Sidonio, Nidra Rodriguez, Kenneth D. Friedman, Amy Shapiro, Hassan Yaish, Shannon Carpenter, Maissaa Janbain, Eric Grabowski, Rajiv Pruthi, Kristina Haley, Courtney Thornburg, Sanjay Ahuja, Mindy Simpson, Ulrike Reiss, Tiffany Lucas, Vinod Balasa, Allison Wheeler
Published in Blood Vessels, Thrombosis & Hemostasis (2025-08-01)Get full text
Article